{"id":9139,"date":"2015-12-02T08:47:37","date_gmt":"2015-12-02T13:47:37","guid":{"rendered":"http:\/\/leavittbrothers.com\/blog\/?p=9139"},"modified":"2015-12-02T08:47:37","modified_gmt":"2015-12-02T13:47:37","slug":"before-the-open-dec-2-7","status":"publish","type":"post","link":"https:\/\/blog.leavittbrothers.com\/?p=9139","title":{"rendered":"Before the Open (Dec 2)"},"content":{"rendered":"

Good morning. Happy Wednesday. <\/span>
\n The Asian\/Pacific markets closed mostly down, but losses were small. China rallied 2.3%, and Hong Kong and Singapore also did well. Japan, South Korea, Malaysia and Indonesia posted losses. Europe is currently mostly down. The Czech Republic, Greece and Poland are down more than 1%; Austria, Russia, Germany, Hungary and Spain are also weak. London is up. Futures here in the States point towards a flat open for the cash market. <\/span>
\n—————<\/span>
\nJoin our email list<\/strong><\/a> and get reports and videos sent directly to you. <\/span>
\n——————
\nThe dollar is up. Oil and copper are down. Gold and silver are down. Bonds are down.<\/span>
\n The S&P cleanly broke out of its 7-day consolidation pattern yesterday. It was a nice move on decent volume, but there’s work to do. There’s lots of resistance overhead from the early-November high and the all-time high established over the summer. Here’s the daily chart. <\/span>
\n\"\"
\n December is the best month of the year, and according to Ryan Detrick, it’s even better when the first day of the month is up > 1%, which is what took place yesterday. <\/span>
\n The internals have improved. The AD line, AD volume line, new highs and others have moved up to confirm the market’s strength…but it obviously has to continue. There isn’t much room for error at these high levels. <\/span>
\n I like the market, but I don’t love it. I’m long but not all in. I’m still in “swing for singles” mode and not placing big bets. I guess you can say I’m content to grind it out. More after the open. <\/span>
\nStock headlines<\/strong> from barchart.com…<\/span>
\n Yahoo! (YHOO -0.30%) jumped over 8% in pre-market trading after the WSJ cited people familiar with the matter as saying the company’s board will consider the sale of its main Internet business.<\/span>
\n Fitbit (FIT +1.74%) rose nearly 3% in pre-market trading after the U.S. International Trade Commission said it would investigate a patent complaint filed by Fotbit against Jawbone Inc.<\/span>
\n Bristol-Myers Squibb (BMY +1.87%) was upgraded to ‘Buy’ from ‘Neutral’ at Guggenheim Securities with a price target of $82.<\/span>
\n Lockheed Martin (LMT +0.47%) won a Pentagon contract worth $914 million to upgrade F-16 aircraft for Singapore’s military.<\/span>
\n Louisiana-Pacific (LPX -2.45%) was added to the ‘Top Pick’ list at RBC.<\/span>
\n Bob Evans (BOBE +0.13%) slid nearly 5% in after-hours trading after it lowered guidance on its fiscal 2016 revenue estimate to $1.35 billion from a prior view of $1.33 billion-$1.39 billion, below consensus of $1.36 billion.<\/span>
\n Mobileye (MBLY -0.32%) rose 1% in after-hours trading after the stock was rated a new ‘Buy’ at Evercore ISI with a price target of $68.<\/span>
\n Powell Industries (POWL -0.31%) slumped 10% in after-hours trading after it reported Q4 adjusted EPS of 45 cents, below consensus of 48 cents, and then lowered guidance on fiscal 2016 adjusted EPS to 65 cents-$1.05, well below consensus of $1.62.<\/span>
\n Guidewire Software (GWRE +2.06%) rose over 4% in after-hours trading after it reported Q1 adjusted EPS of 7 cents, over double consensus of 3 cents.<\/span>
\n Ascena Retail (ASNA +3.97%) jumped over 7% in after-hours trading after it reported Q1 adjusted EPS of 36 cents, higher than consensus of 29 cents.<\/span>
\n Culp (CFI +2.66%) reported Q2 EPS of 41 cents, better than consensus 40 cents, although Q2 revenue of $77.0 million was below consensus of $77.6 million.<\/span>
\n OncoGenex Pharmaceuticals (OGXI +1.55%) plunged over 25% in after-hours trading after it said some patients in its prostate cancer drug study did not respond to treatment with its custirsen drug.<\/span>
\nEarnings and Economic Numbers<\/strong> from seekingalpha.com…<\/span>
\n Today’s Economic Calendar
\n 7:00 MBA Mortgage Applications
\n 8:15 ADP Jobs Report
\n 8:30 Productivity and Costs
\n 8:30 Gallup U.S. Job Creation Index
\n 9:00 Daniel Tarullo speech
\n 10:30 EIA Petroleum Inventories
\n 12:25 PM Janet Yellen speech
\n 2:00 PM Fed’s Beige Book
\n 3:40 PM Fed’s Williams: Economic Outlook<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span>
\nToday’s Earnings here<\/a><\/span>
\nOther<\/strong>…<\/span>
\ntoday’s upgrades\/downgrades<\/a> from briefing.com<\/span>
\nthis week’s Earnings<\/a><\/span>
\nthis week’s Economic Numbers<\/a><\/span>
\n